Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 2 6Phase 1 5Phase 3 3Phase EARLY_PHASE1 1Phase 4 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 29Genitourinary 23Thoracic 20Breast 19Other hematologic neoplasm 16Lymphoid 14Dermatologic 10Gynecologic 8Classical hematology 8Head & Neck 6Myeloid 5CNS 4Tumor-Agnostic 3Sarcoma 3Other 3Plasma cell 2Endocrine 2Other solid neoplasm 1Other neoplasm 1NET 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Lymphoma 1HTLV-I Infections 1

Interventions

peginterferon alfa-2b 1Zidovudine 1Valproic Acid 1Interferon alpha-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Other neoplasm × Clear all
NCT00854581 2018-04-17

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

University of Miami

Phase 4 Terminated
13 enrolled 15 charts
LymphoidOther hematologic neoplasmOther neoplasm

Lymphoma, Precancerous Conditions, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡